Avai Bio, Inc.
AVAIOTCTechnology● Active
$0.20
+$0.01(+2.84%)
Market Cap$27581274
P/E Ratio—
52W High$0.828
52W Low$0.16
Avai Bio, Inc. (AVAI) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AVAI · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) |
| Gross Margin %(computed) | — | — | -23.11% | 17.70% | -6.04% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — | -131.58% | -37.24% | -25.02% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | — | -126.28% | -13.73% | -24.90% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $-0.02 | $-0.01 | $-0.00 | $-0.01 |
| Wtd Avg Shares | 0.13B | 0.09B | 0.04B | 0.03B | 0.03B |
| EBITDA | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | -117.80% | -8.55% | -20.22% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Avai Bio, Inc. data
About Avai Bio, Inc. (AVAI) Income Statement
Avai Bio, Inc. (AVAI) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, AVAI reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.00B) — a net profit margin of —.
Frequently asked questions
AVAI · 4 questionsAvai Bio, Inc. (AVAI) reported revenue of $0.00B for 2025, down —% year-over-year.
AVAI revenueAVAI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09